Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simples virus type 1 viral vector precludes experimental allergic encephalomyelitis

Gene Therapy

Volumn 8, Issue 10, 2001, Pages 769-777

  Broberg, E ^a,b   Setala N ^a   Roytta M ^a   Salmi, A ^a   Eralinna J P ^a   He, B ^c   Roizman, B ^c   Hukkanen, V ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytokines; EAE; Gene therapy; Herpes simplex virus vectors

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; VIRUS VECTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DOWN REGULATION; FEMALE; GENE DELETION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; INJECTION; LEUKOCYTE; MOUSE; MOUSE STRAIN; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RECORDING; REGULATORY MECHANISM; RELAPSE; SPINAL CORD; SYMPTOM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TIME; TISSUE SECTION; VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; WEIGHT;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0034985881     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301465     Document Type: Article

References (42)

1. Experimental allergic encephalomyelitis: A model for multiple sclerosis
2. The T lymphocyte in experimental allergic encephalomyelitis
3. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis
4. The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis
5. Reciprocal stimulation between TNF-a and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis
6. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice
7. Progress in determing the causes and treatment of multiple sclerosis
8. Interferon b in multiple sclerosis: Is IL-12 suppression the key?
9. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients
10. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4 deficient C57BL/6 and BALB/c mice
11. Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination
12. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination
13. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental allergic encephalomyelitis
14. Nasal administration of transforming growth factor-b1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis
15. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors
16. Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide
17. Replication competent herpes simplex viral vectors for cancer therapy
18. The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors
19. Herpes simplex viruses and their replication
20. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system
21. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
22. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
23. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
24. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system
25. 134.5 gene and transcribed by an RNA 3′ coterminal with the unspliced latency-associated transcript
26. The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome
27. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor a factor b
28. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery
29. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1
30. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1
31. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1
32. Viral facilitation and treatment of experimental allergic encephalomyelitis in Balb/c mice
33. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: An effect of the novel anti-inflammatory drug lisofylline
34. Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors
35. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox
36. A novel and efficient regimen for producing chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) in SJL mice
37. Phenotypic properties of herpes simplex virus 1 containing a depressed open reading frame P gene
38. Physical stage of the neuroantigen in adjuvant emulsion determines encephalitogenicity in BALB/c mouse
39. A method for the covalent attachment of cells to glass slides for use in immunohistochemical assays
40. Time-resolved fluorescence (TRF) PCR assay for detection of herpes simplex virus in cerebrospinal fluid
41. Experimental autoimmune encephalomyelitis of the BALB/c mouse
42. Detection of herpes simplex virus latency-associated RNA in mouse trigeminal ganglia by in situ hybridization using nonradioactive digoxigenin-labeled DNA and RNA probes